课题基金 / 基金详情

Oat protein as a sustainable protein source: Structure-function characterization and utilization in novel applications

Oat protein as a sustainable protein source: Structure-function characterization and utilization in novel applications
燕麦蛋白作为可持续的蛋白质来源:结构功能表征和新应用中的利用
批准号:
RGPIN-2022-04505
负责人:
Malalgoda, Maneka
金额:
$1.89万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-01-01 至 2023-12-31

项目摘要

项目成果

Malalgoda, Maneka的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The demand for protein ingredients is rising globally, and oat protein has gained renewed interest due to its favorable nutritional profile. However, one of the main concerns in relation to oat protein consumption, is its allergenic potential to illicit the immune response associated with celiac disease (CD). Given the increasing incidence of CD globally, and especially in Canada, it is imperative to understand the celiac allergenicity of oat protein to develop celiac-safe oat protein ingredients. Given my background in analytical techniques such as mass spectrometry in the quantitation of protein allergens, I am uniquely positioned to investigate the celiac allergenicity of oat, an area that has not been extensively studied, thereby gain novel foundational information that will greatly advance our knowledge about celiac disease initiating proteins in oat. Long-term goal: Build a framework that would facilitate the accurate detection and quantitation of grain-based allergens and develop the fundamental knowledge that would lead to the development of grain-based ingredients that are safe for all consumers. The short-term goals of this proposed NSERC Discovery research program over the next 5 years are to explore how oat protein celiac antigenicity varies across diverse oat cultivars and determine strategies to reduce the celiac antigenicity of oat. The specific objectives are: (i)Develop a validated tandem mass spectrometry-based method for the quantitative analysis of celiac epitopes in oat and determine the variability of celiac antigenicity among diverse oat cultivars. (ii)Identify specific avenin protein fractions when separated based on hydrophobicity, and determine the celiac antigenicity of the different protein fractions (iii)Develop novel protein modification approaches to reduce the amount of celiac epitopes in diverse cultivars with the goal of developing celiac-safe oat protein isolates Impact of the research program: With the acquisition of new knowledge regarding quantitatively analyzing oat protein celiac allergenicity through robust and highly sensitive proteomics techniques, the proposed program will open prospects in determining the allergenicity in oat as well as other grains. The proposed program will also provide insights as to how we could exploit the natural variation in oat protein chemistry to develop oat protein ingredients that are hypoallergenic and safe for consumption by all consumers. By way of unravelling how protein molecular structure can be manipulated to reduce oat protein celiac allergenicity, the proposed program will spearhead novel research in the area of hypoallergenic protein ingredient development. Overall, the proposed work will also benefit the Canadian grain production and processing industry by determining how to produce protein ingredients that are safe for all consumers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Oat protein as a sustainable protein source: Structure-function characterization and utilization in novel applications
  • 批准号:
    DGECR-2022-00304
  • 项目类别:
    Discovery Launch Supplement
  • 资助金额:
    $0.91万
  • 财政年份:
    2022
  • 负责人:
    Malalgoda, Maneka
  • 依托单位:
国内基金
海外基金
子宫内膜间质与巨噬细胞之间通过Protein S-MerTK-Apelin信号对 话促进子宫腺肌病蜕膜化缺陷的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    吕海宁
  • 依托单位:
有翅与无翅蚜虫差异分泌唾液蛋白Cuticular protein在调控植物细胞壁免疫中的功能
  • 批准号:
    32372636
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2023
  • 负责人:
    郭慧娟
  • 依托单位:
原发性开角型青光眼中SIPA1L1促进小梁网细胞外基质蛋白累积升高眼压的作用机制
  • 批准号:
    82371054
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    郭涛
  • 依托单位:
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
  • 批准号:
    82370976
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    郑凌艳
  • 依托单位: